Anti-hepatoma immunotherapy of Pholiota adiposa polysaccharide-coated selenium nanoparticles by reversing M2-like tumor-associated macrophage polarization
J Xu, Z Liu, S Zhang, J Xiang, H Lan, Y Bao - International Journal of …, 2024 - Elsevier
Targeting macrophages to regulate the tumor microenvironment is a promising strategy for
treating cancer. This study developed a stable nano drug (PAP-SeNPs) using Se …
treating cancer. This study developed a stable nano drug (PAP-SeNPs) using Se …
A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices
CY Wei, GY Chau, PH Chen, CA Liu, YH Huang… - Scientific reports, 2020 - nature.com
There has been insufficient investigation of the differences in long-term outcomes between
surgical resection (SR) and radiofrequency ablation (RFA) among patients with …
surgical resection (SR) and radiofrequency ablation (RFA) among patients with …
The current role of radiofrequency ablation in the treatment of intrahepatic recurrent hepatocellular carcinoma
R Fu, W Ling - Journal of Surgical Oncology, 2023 - Wiley Online Library
The incidence of recurrent hepatocellular carcinoma (HCC) after initial curative treatments is
relatively high. However, there is still the lack of standard management of recurrent HCC …
relatively high. However, there is still the lack of standard management of recurrent HCC …
Effectiveness of radiofrequency ablation versus transarterial chemoembolization for recurrent hepatocellular carcinoma: A meta-analysis
H Gou, S Liu, G Zhu, Y Peng, X Li… - Acta Radiologica …, 2022 - journals.sagepub.com
Background Both transarterial chemoembolization (TACE) and radiofrequency ablation
(RFA) are effective methods for the treatment of recurrent hepatocellular carcinoma (RHCC) …
(RFA) are effective methods for the treatment of recurrent hepatocellular carcinoma (RHCC) …
Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation
E Gigante, Y Haddad, JC Nault, O Sutter, E Abou Ali… - Scientific Reports, 2022 - nature.com
Aggressive intrasegmental recurrence (AIR) is a form of local recurrence associated with a
dismal prognosis and defined by multiple nodules or by an infiltrative mass with a tumor …
dismal prognosis and defined by multiple nodules or by an infiltrative mass with a tumor …
The evolution of interventional oncology in the 21st century
T Helmberger - The British Journal of Radiology, 2020 - academic.oup.com
Interventional oncology (IO) has proven to be highly efficient in the local therapy of
numerous malignant tumors in addition to surgery, chemotherapy, and radiotherapy. Due to …
numerous malignant tumors in addition to surgery, chemotherapy, and radiotherapy. Due to …
Comparison of overall survival between surgical resection and radiofrequency ablation for hepatitis B-related hepatocellular carcinoma
MH Hur, JH Lee, JY Kim, JH Hong, MK Park, HJ Cho… - Cancers, 2021 - mdpi.com
Simple Summary The effectiveness of surgical resection and radiofrequency ablation in
early hepatocellular carcinoma is still controversial because previous studies show …
early hepatocellular carcinoma is still controversial because previous studies show …
[HTML][HTML] The clinical value of total plasma cell-free DNA in hepatitis B virus-related hepatocellular carcinoma
D Wang, X Hu, G Long, L Xiao, ZM Wang… - Annals of translational …, 2019 - ncbi.nlm.nih.gov
Background Circulating cell-free DNA (cfDNA), which is present in the blood, is related to the
apoptosis and necrosis of cancer cells; inflammation also influences the total plasma level of …
apoptosis and necrosis of cancer cells; inflammation also influences the total plasma level of …
An evaluation of 20-year survival of radiofrequency ablation for hepatocellular carcinoma as first-line treatment
XM Bai, ZH He, H Wu, W Yang, S Wang… - European Journal of …, 2023 - Elsevier
Objectives To evaluate the changes in clinical characteristics, overall survival (OS), and
progression-free survival (PFS) by investigating a 20-year cohort of patients with HCC who …
progression-free survival (PFS) by investigating a 20-year cohort of patients with HCC who …
Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure
Objectives To compare the therapeutic outcomes and safety of radiofrequency (RF) ablation
for subcardiac and non-subcardiac hepatocellular carcinoma (HCC) and to evaluate the risk …
for subcardiac and non-subcardiac hepatocellular carcinoma (HCC) and to evaluate the risk …